PACA

Assa Abloy Quarterly Report Q1 2024

Retrieved on: 
星期三, 四月 24, 2024
Acquisition, PACA, HHI, Growth, EMEIA

Organic sales growth was stable in Entrance Systems, but declined in Americas, Asia Pacific, EMEIA and in Global Technologies.

Key Points: 
  • Organic sales growth was stable in Entrance Systems, but declined in Americas, Asia Pacific, EMEIA and in Global Technologies.
  • Three acquisitions with combined annual sales of about SEK 2,000 M were completed in the quarter.
  • The divestment of PACA in France was finalized.
  • The operating margin1 (EBIT) excluding the acquisition of HHI and divestment of the Emtek/U.S.

Assa Abloy Quarterly Report Q1 2024

Retrieved on: 
星期三, 四月 24, 2024
Acquisition, PACA, HHI, Growth, EMEIA

Organic sales growth was stable in Entrance Systems, but declined in Americas, Asia Pacific, EMEIA and in Global Technologies.

Key Points: 
  • Organic sales growth was stable in Entrance Systems, but declined in Americas, Asia Pacific, EMEIA and in Global Technologies.
  • Three acquisitions with combined annual sales of about SEK 2,000 M were completed in the quarter.
  • The divestment of PACA in France was finalized.
  • The operating margin1 (EBIT) excluding the acquisition of HHI and divestment of the Emtek/U.S.

Yachting at the heart of economic challenges in the region Sud and Monaco

Retrieved on: 
星期五, 二月 9, 2024
Workforce, Policy, PACA, Tourism, Principality, Yacht club, YCM, Pleasure, CRT, Ferretti Group, Economic development, Monégasque

This is what emerges from the economic symposium 'La Belle Classe Superyachts', organized by the Yacht Club de Monaco.

Key Points: 
  • This is what emerges from the economic symposium 'La Belle Classe Superyachts', organized by the Yacht Club de Monaco.
  • At the center of the event is the economic impact of yachting on a global level with a focus on the southern region of France and the Principality.
  • The yachting sector numbers 411 establishments or 3.7% of total businesses in the Principality, and 1,429 jobs, representing 2.4% of Monaco’s workforce.
  • Specialised design activities alone represent over 20 million euros of yachting revenue in 2022.

ASSA ABLOY sells PACA ascenseur in France to KONE

Retrieved on: 
星期五, 二月 2, 2024
Acquisition, CFO, ASSA, PACA, Management

STOCKHOLM, Feb. 2, 2024 /PRNewswire/ -- ASSA ABLOY has sold its elevator maintenance business PACA ascenseur ("PACA") in France to KONE.

Key Points: 
  • STOCKHOLM, Feb. 2, 2024 /PRNewswire/ -- ASSA ABLOY has sold its elevator maintenance business PACA ascenseur ("PACA") in France to KONE.
  • PACA is an elevator maintenance business located in Southern France.
  • "I find it satisfying that with KONE, PACA and its employees and customers get a committed long-term owner, creating new opportunities for the future and I wish them every success," says Nico Delvaux, President and CEO of ASSA ABLOY.
  • We believe we have found a good home for the PACA business, which will receive full attention from its new owners to support further development," says Massimo Grassi, Executive Vice President of ASSA ABLOY and Head of Entrance Systems Division.

ASSA ABLOY sells PACA ascenseur in France to KONE

Retrieved on: 
星期五, 二月 2, 2024
Acquisition, CFO, ASSA, PACA, Management

STOCKHOLM, Feb. 2, 2024 /PRNewswire/ -- ASSA ABLOY has sold its elevator maintenance business PACA ascenseur ("PACA") in France to KONE.

Key Points: 
  • STOCKHOLM, Feb. 2, 2024 /PRNewswire/ -- ASSA ABLOY has sold its elevator maintenance business PACA ascenseur ("PACA") in France to KONE.
  • PACA is an elevator maintenance business located in Southern France.
  • "I find it satisfying that with KONE, PACA and its employees and customers get a committed long-term owner, creating new opportunities for the future and I wish them every success," says Nico Delvaux, President and CEO of ASSA ABLOY.
  • We believe we have found a good home for the PACA business, which will receive full attention from its new owners to support further development," says Massimo Grassi, Executive Vice President of ASSA ABLOY and Head of Entrance Systems Division.

Annexon Reports Significant Progress with its Priority Programs and Third Quarter 2023 Financial Results

Retrieved on: 
星期一, 十一月 13, 2023
Molecule, Ophthalmology, Visual acuity, Investment, HD, EMA, Research, Kidney, Autoimmune disease, Driver, C3, Conference, R, Facial muscles, Inflammation, Treatment, Meta-analysis, American Academy, American Society of Nephrology, G&A, Guillain, Society, Letter, Paratriathlon, European Medicines Agency, American Academy of Ophthalmology, Professional, C4, AAO, System, Nephrology, AMD, Immunoglobulin therapy, PACA, Plasma, Disease, Complement component 1q, Medicine, Complement system, FDA, Geographic atrophy, GBS, ARCHER, C5, HIV disease progression rates, Risk management, Pharmaceutical industry, Vaccine, Cryptocurrency, Patient, LN, ALS

EMA orphan drug designation requires that a novel rare disease therapeutic demonstrates the potential for significant benefit over available therapies.

Key Points: 
  • EMA orphan drug designation requires that a novel rare disease therapeutic demonstrates the potential for significant benefit over available therapies.
  • Importantly, Annexon also announced that it has achieved target enrollment of 225 patients in the randomized, double-blind, placebo-controlled Phase 3 trial of ANX005 in patients with GBS.
  • Research and development (R&D) expenses: R&D expenses were $27.9 million for the quarter ended September 30, 2023, reflecting the advancement of the company’s priority programs, including GBS, GA and ANX1502, compared to $27.9 million for the quarter ended September 30, 2022.
  • General and administrative (G&A) expenses: G&A expenses were $6.9 million for the quarter ended September 30, 2023, compared to $8.2 million for the quarter ended September 30, 2022.

Point Blank Enterprises Exhibiting at the Association of the United States Army (“AUSA”) 2022 Annual Conference and Exposition

Retrieved on: 
星期一, 十月 10, 2022
AUSA, D.C, STC, PACA, TPG, Cummins, Special Protection Group, ATG, Roush, Conference, G&G, Exposition, Future Vertical Lift, United States Senate Commerce Subcommittee on Consumer Protection, Product Safety, and Data Security, Federal, Infantry fighting vehicle, Technology, Solution, Australian First Tactical Air Force, Company, Industry, Association, Infantry, Association of the United States Army, FVL, GLOBE, Point-blank range, Model-based systems engineering, Tulpar (IFV), 2009 Davis Cup, MBSE, Advanced Technology Group, Army, Risk management, Booth

POMPANO BEACH, Fla., Oct. 10, 2022 (GLOBE NEWSWIRE) -- Point Blank Enterprises Inc. (Point Blank) is honored to participate in the Association of the United States Army (AUSA) 2022 Annual Conference and Exposition.

Key Points: 
  • POMPANO BEACH, Fla., Oct. 10, 2022 (GLOBE NEWSWIRE) -- Point Blank Enterprises Inc. (Point Blank) is honored to participate in the Association of the United States Army (AUSA) 2022 Annual Conference and Exposition.
  • At this years event, Point Blank will be presenting details about the companys Optionally Manned Fighting Vehicle (OMFV) design at Booth 3205.
  • In addition to a disciplined MBSE approach, Point Blank has adhered strictly to the Armys Modular Open Systems Architecture (MOSA) standardization initiative.
  • Visit Point Blank in Booth #3205 at the 2022 AUSA Conference in Washington, D.C. Oct 10-12.

Roca Therapeutics completes seed funding round

Retrieved on: 
星期四, 九月 22, 2022
Incubator, Renal cell carcinoma, Knowledge, BPI, Life, Macrophage, Southern Regional Council, Therapy, Foundation, Patient, Nice, PACA, CEO, Glaucoma, CSO, UCA, General partnership, Uveal melanoma, Board, Research, ROCA, Executive, Science, Immunosuppression, Pharmaceutical industry

Nice, France - 22 September 2022 - Roca Therapeutics, a leading biotech startup specialized in the discovery and development of small molecules addressing severe life-threatening disorders caused by hypervascularization and macrophages M2 driven immunosuppression, today announced the closing of a seed funding round led by 3B Future Health Fund II and SATT Sud-Est.

Key Points: 
  • Nice, France - 22 September 2022 - Roca Therapeutics, a leading biotech startup specialized in the discovery and development of small molecules addressing severe life-threatening disorders caused by hypervascularization and macrophages M2 driven immunosuppression, today announced the closing of a seed funding round led by 3B Future Health Fund II and SATT Sud-Est.
  • Roca Therapeutics has received grants and non-dilutive funding from BPI (French Public Investment Bank), PACA Cancrople, UCA (Universit Cote d'Azur), Eurobiomed Grand Sud (competitive cluster), the Incubator PACA-Est, Nice Metropole, and Southern Regional council.
  • We are excited to support ROCA Therapeutics talented team in converting their highly promising and valuable research into new treatments.
  • We are proud and grateful to have to the opportunity to support the creation of Roca Therapeutics.

Smartfluence, the fastest growing SaaS influencer marketing platform, closes $2.15 Million Seed Round Led by PACA Ventures

Retrieved on: 
星期二, 八月 9, 2022
Industry, CEO, CA, Growth, PACA, Software as a service, PETS, Instagram, Twitter, Acceleration, Social media, Cryptocurrency, Public relations, Facebook

NEW YORK, Aug. 9, 2022 /PRNewswire/ -- Smartfluence , the leading SaaS influencer marketing platform, announced a seed round investment of $2.15 million led by PACA Ventures.

Key Points: 
  • NEW YORK, Aug. 9, 2022 /PRNewswire/ -- Smartfluence , the leading SaaS influencer marketing platform, announced a seed round investment of $2.15 million led by PACA Ventures.
  • Ira Lubert and Jo Webber, both principals at PACA Ventures, will be joining Smartfluence's board of directors.
  • Smartfluence, the fastest growing SaaS influencer marketing platform, closes $2.15M Seed Round Led by PACA Ventures
    Smartfluence, founded in 2018, is changing the way brands and social media influencers engage with each other by utilizing a quantitative analytical approach.
  • PACA Ventures partners with visionary founders to build exceptional high-growth tech companies from Seed through Series B.

Point Blank Enterprises completes Optionally Manned Fighting Vehicle (OMFV) System Requirements Review, opens Detroit Office and selects Cummins Inc.’s Advanced Combat Engine (ACE)

Retrieved on: 
星期五, 三月 4, 2022
Design, Australian First Tactical Air Force, Land systems, 2009 Davis Cup, GLOBE, PACA, Department of Defence, ACE, Ethnic minorities in the U.S. armed forces during World War II, Program, MCR, Liberty, TPG, Company, United States Senate Commerce Subcommittee on Consumer Protection, Product Safety, and Data Security, SRR, Cummins, G&G, Special Protection Group, PBE, Advanced Technology Group, Technology, ATG, Department, Federation, Risk management

Point Blank Enterprises (PBE) and partner Keshik Mobile Power Systems (Keshik) recently completed the US ARMYs OMFV System Requirements Review (SRR) and Maintainability Concept Review (MCR), both of which are critical OMFV Phase 2 milestones.

Key Points: 
  • Point Blank Enterprises (PBE) and partner Keshik Mobile Power Systems (Keshik) recently completed the US ARMYs OMFV System Requirements Review (SRR) and Maintainability Concept Review (MCR), both of which are critical OMFV Phase 2 milestones.
  • To continue to build our combined capabilities, PBE and Keshik have opened a Detroit area office for our Land Systems engineering and program management team.
  • Additionally, PBE and Keshik are proud to announce the selection of the Cummins Advanced Combat Engine (ACE) for our OMFV offering.
  • Point Blank Enterprises, Inc. is a leading provider of high-performance protective solutions, including bullet, fragmentation, and stab resistant apparel and related products and services.